UBT251A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity

Sponsor:

Novo Nordisk A/S

Code:

NCT07395687

Conditions

Overweight

Obesity

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

UBT251

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Novo Nordisk A/S on 2026-04-21.